Navigation Links
New Conference Offers Solutions for Success in the Growing Biologics Market

PRINCETON, N.J., Aug. 2, 2011 /PRNewswire/ -- Informex, the leading meeting place for buyers and sellers of high-value chemistry, today announced the introduction of a new conference, 'Business Strategies for Biologics: Positioning and Partnering for the Biopharmaceutical Evolution' to be hosted October 5-6th, 2011 in Boston, Massachusetts.  The two day conference will cover on-trend topics regarding the future of pharma, sourcing strategies for biologics, regulatory challenges, and opportunities in biosimilars. Speakers will include senior personnel from Merck, Novartis, Pfizer, Sanofi, Genentech/Roche, and Boehringer Ingelheim.

"We created this new Biologics Conference to provide attendees with valuable and relevant content to help them successfully navigate the changes and challenges in the rapidly growing biologics sector," Jennifer Jessup, Global Brand Director, Informex noted. She continued, "With Industry forecasts indicating that by 2014, 50% of the top 100 and seven of the top 10 drugs will be biologics(1). This is a rare opportunity for companies to strategize and get settled into an early stage market with expectations for tremendous growth."

As the blockbuster drug patents begin to expire, a massive shift towards R&D of biologics and biosimilars has been happening industry-wide. Chemicals companies are seeing this translated into redefined global business demands. It is imperative for pharma companies to have the tools available to strategize  for shifting their pipelines into this sort of R&D. The Biologics Conference will provide these tools, and will also offer valuable insight into evaluating and maximizing competitive advantages as more and more services are being outsourced globally to satisfy the market.

The Biologics conference will provide opportunities to learn from and network with department heads, directors and C-level executives from big Pharma, CMOs, CROs, CRAMs, Generics, Biotechs, and Research and Academic Institutions in one central location. Some of the featured speakers at the conference include: Merck Director of Scientific Liaison Biologics, Stephen O'Keefe,   Sanofi US VP of Regulatory Policy, Brian Harvey, Boehringer Ingelheim Global Sourcing Manager, Dr. Enric Bosch Rado, and Genetech/Roche Senior Medical Director, Frank Scappaticci. The Business Strategies for Biologics complete program has been created to offer delegates a unique forum to work towards evaluating and dissecting how to take advantage of the rapidly advancing Biologics sector.

Early-bird registration will close on August 19, 2011. For more information about the Business Strategies for Biologics Conference in Boston, please visit us online at:  

For more information on Informex, please visit:


About UBM Live: UBM Live is a division of UBM Plc (LSE: UBM) a leading provider of business information services to the maritime, travel, fashion, technology, healthcare, media, and property industries. UBM offers services in trade shows, online, news distribution, and publishing to customers across the globe. Its brands are represented in more than 30 countries and are organized into specialist teams that serve their business communities helping them excel in their market by working effectively and efficiently. For more information, go to

About Informex: Organized by UBM Live, Informex is the leading meeting place for buyers and sellers of high-value chemistry for a broad range of applications. As the premier, must-attend, event for the chemical industry for the past 27 years, Informex is a marketplace for networking and doing business in the fine, custom and specialty chemical manufacturing industry. The show traces its origin to a group of members from the Society of Chemical Manufacturers and Associates (SOCMA) who were looking for an annual place to meet and do business. Each year the event brings together an international mix of more than 4,000 fine and specialty chemicals professionals and 500 exhibitors for the all encompassing, 4 day event.

SOURCE Informex
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
2. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results
3. The Science of Music Meets the Art of Medicine - ARIMM 3rd Annual Conference at IPFW, September 12-13, 2008
4. InterMune to Present at Canaccord Adams Conference
5. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2008
6. Verenium Corporation to Present at Canaccord Adams 28th Annual Global Growth Conference
8. China Sky One Medical, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
9. Bionovo to Present at Canaccord Adams Global Growth Conference
10. China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
11. Pharmasset to Present at the Canaccord Adams Global Growth Conference on Tuesday, August 12th
Post Your Comments:
(Date:11/24/2015)... India , November 24, 2015 ... a new market research report "Oligonucleotide Synthesis Market by ... Application (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, ... 2020", published by MarketsandMarkets, the market is expected to ... Million in 2015, at a CAGR of 10.1% during ...
(Date:11/24/2015)... IN (PRWEB) , ... November 24, 2015 , ... The ... newest Special Interest Group (SIG), MultiGP, also known as Multirotor Grand Prix, to represent ... the last few years. Many AMA members have embraced this type of racing and ...
(Date:11/24/2015)... 24, 2015 --> ... report released by Transparency Market Research, the global non-invasive ... CAGR of 17.5% during the period between 2014 and ... Global Industry Analysis, Size, Volume, Share, Growth, Trends and ... testing market to reach a valuation of US$2.38 bn ...
(Date:11/24/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: ... 11,000 post-share consolidation (or 1,100,000 pre-share consolidation) Series ... Warrants") subject to the previously disclosed November 1, ... which will result in the issuance of 365,518 ... issuance of such shares, there will be approximately ...
Breaking Biology Technology:
(Date:10/29/2015)... Daon, a global leader in mobile biometric ... new version of its IdentityX Platform , IdentityX ... have already installed IdentityX v4.0 and are ... FIDO UAF certified server component as an option ... features. These customers include some of the largest and ...
(Date:10/27/2015)... -- In the present market scenario, security is one ... verticals such as banking, healthcare, defense, electronic gadgets, and ... secure & simplified access control and growing rate of ... bank accounts, misuse of users, , and so on. ... and smartphones are expected to provide potential opportunities for ...
(Date:10/26/2015)... -- Delta ID Inc., a company focused on bringing secure ... announced its ActiveIRIS® technology powers the iris recognition feature ... NTT DOCOMO, INC in Japan . ... include iris recognition technology, after a very successful introduction ... 2015, world,s first smartphone to have this capability. ...
Breaking Biology News(10 mins):